SHYTOMEL DUO 47 combines two thyroid hormones — T4 and T3 — providing both steady and rapid hormonal effects. Levothyroxine maintains stable baseline levels, while liothyronine ensures faster metabolic response, improving energy and mental clarity.
Benefits include:
Clinical studies have shown that combined T4+T3 therapy may improve patient well-being compared to T4 monotherapy, particularly in individuals with low serum T3 despite normal T4 levels.
Indicated for hormone replacement therapy in primary or secondary hypothyroidism, post-thyroidectomy conditions, autoimmune thyroiditis, and prevention of goiter recurrence. Helps restore thyroid hormone balance and metabolic stability.
Take orally in the morning on an empty stomach with water. Dosage should be individualized based on laboratory tests and clinical response. Adjustments must be made under medical supervision.
Contraindications
Side Effects
